Cargando…
Halogenated Flavonoid Derivatives Display Antiangiogenic Activity
Antiangiogenic agents attenuate tumours’ growth and metastases and are therefore beneficial as an adjuvant or standalone cancer regimen. Drugs with dual antiproliferative and antiangiogenic activities can achieve anticancer efficacy and overcome acquired resistance. In this study, synthetic flavones...
Autores principales: | Khater, Mai, Watson, Kimberly A., Boateng, Samuel Y., Greco, Francesca, Osborn, Helen M. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331694/ https://www.ncbi.nlm.nih.gov/pubmed/35897938 http://dx.doi.org/10.3390/molecules27154757 |
Ejemplares similares
-
Antiangiogenic Activity of Flavonoids: A Systematic Review and Meta-Analysis
por: Khater, Mai, et al.
Publicado: (2020) -
Antiangiogenic Effect of Flavonoids and Chalcones: An Update
por: Mirossay, Ladislav, et al.
Publicado: (2017) -
Bioorthogonal activation of prodrugs, for the potential treatment of breast cancer, using the Staudinger reaction
por: Mitry, Madonna M. A., et al.
Publicado: (2023) -
Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes
por: Khater, Mai, et al.
Publicado: (2022) -
Impact of specific functional groups in flavonoids on the modulation of platelet activation
por: Ravishankar, Divyashree, et al.
Publicado: (2018)